IDStewardship

OCTOBER 28, 2022

In this article a PGY2 Infectious Diseases Pharmacy Resident discusses social media as a resource for pharmacy residency recruitment, providing insights for both programs and candidates. . Authored by: Hunter O. Rondeau, Pharm.D. Article Posted 28 October 2022. Virtual recruitment for post-graduate residency programs continues to find its place, especially now with the upcoming in-person Midyear after two years of an “online-only” environment.

Documentation 229

Documentation 229

Drug Topics

OCTOBER 28, 2022

State of Skin Sensitivity Report raises awareness of the causes of skin sensitivity and its effect on the mind.

185

185

STAT

OCTOBER 28, 2022

There are increasing signs that flu season is off to a very early start in parts of the United States, with the cumulative hospitalization rate higher than it has been at this point in the fall for more than a decade, the Centers for Disease Control and Prevention reported Friday. In its weekly FluView report , the CDC estimated that there have already been 880,000 influenza illnesses, 6,900 flu hospitalizations, and 360 deaths caused by flu this season, which started at the beginning of October

Hospitals 120

Hospitals 120

Pharmacy Times

OCTOBER 28, 2022

Findings are encouraging for individuals with cancer who are receiving immune checkpoint inhibition treatment and want to get a third vaccine dose, investigators said.

Immunization 123

Immunization Vaccines 123

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmaceutical Technology

OCTOBER 28, 2022

Drug discovery and development is an incredibly expensive and time-consuming process, taking between 12 and 18 years, and costing on average between $2 billion and $3 billion. Considering the low chances of success, with only 10% of drug candidates making it into clinical development, pharma companies must prevent the increased erosion of profit margins.

Compounding 124

Compounding 124

Drug Topics

OCTOBER 28, 2022

The study looked at cancer patients as a group, but senior author notes that ‘that treatments for blood cancers are very costly and many of them require treatment for long periods of time.’.

98

98

pharmaphorum

OCTOBER 28, 2022

In June, NHSE and NICE published details on the Innovative Medicines Fund, which will help improve patient access to cutting-edge medicines, with a particular focus on rare diseases, and ensure global pharmaceutical and biotech organisations continue to prioritise the UK as a launch destination. Join us on Wednesday 23rd November at 12:30 GMT / 13:30 CET / 7:30 am EST as the panel discuss how the Innovative Medicines Fund works, what the implications are for industry organisations in securing fu

122

122

Pharmacy Times

OCTOBER 28, 2022

In a panel, pharmacy technicians discuss the future of pharmacy technicians in United States, Portugal, and the United Kingdom.

132

132

Drug Topics

OCTOBER 28, 2022

The keynote address for the fall 2022 Total Pharmacy Solutions Summit looks at where independent pharmacy is and what needs to be done.

Independent Pharmacies 98

Independent Pharmacies 98

Pharmacy Times

OCTOBER 28, 2022

Modifications related to final product verifications, immunizations, and remote work loom on the horizon for 2023.

Immunization 132

Immunization 132

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

European Pharmaceutical Review

OCTOBER 28, 2022

Biotech firm Omega Therapeutics, Inc. revealed the first patient to be dosed with OTX-2002, the first programmable mRNA therapeutic for c-Myc (MYC) oncogene overexpression, which targets cancer cells while sparing healthy cells. OTX-2002 targets c-Myc (MYC), a key oncogene and master transcription factor that regulates cell proliferation, differentiation and apoptosis and plays a major role in over half of all human cancers.

106

106

STAT

OCTOBER 28, 2022

Two decades ago, the Bush administration threw a wrench in health data privacy, making it possible for many health care organizations to share medical information without patients’ consent so long as it was being used to improve treatment or streamline business operations. Today, the health data marketplace looks vastly different. Medical records are being amassed by commercial data brokers and sold to insurance companies, and drug and device manufacturers, along with personal information

Medical Records 100

Medical Records Insurance 100

Drug Topics

OCTOBER 28, 2022

Mitchel Rothholz, RPh, MBA, and Jeff Goad, PharmD, MPH, share insights regarding COVID-19 potentially achieving endemic status.

98

98

STAT

OCTOBER 28, 2022

The National Academy of Medicine launched its National Plan for Health Workforce Well-Being in early October. Citing years of research defining the causes and effects of burnout in health professions, internationally recognized leaders in health care devoted two hours to a launch event for an all-hands-on-deck call to action supporting their plan, which had been developed over the course of several years by the academy’s Action Collaborative on Clinician Well-Being and Resilience.

100

100

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

OCTOBER 28, 2022

Pharmacists can remind parents to have an EpiPen on hand and to carefully review candy after trick-or-treating.

123

123

NF2 BioSolutions

OCTOBER 28, 2022

Chronic pain. I wake up in the morning & before I open my eyes I assess, has yesterday’s headache dissolved as I slept? Has the neuropathic pain in my hands & feet left the building? How about that troublesome hip & lower back pain? Oh & then there’s the facial pain. Eenie meanie miney mo…. It burns, it stabs, it sends little electric shocks shooting down my body & firing off in my foot.

98

98

STAT

OCTOBER 28, 2022

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured moment to daydream about weekend plans. Our agenda is still shaping up. For now, we plan to hang with Mrs. Pharmalot, romp with the official mascot, and search for the Great Pumpkin. And what about you? This remains a fine time to enjoy the great outdoors.

Dosage 98

Dosage Chemotherapy Hospitals 98

pharmaphorum

OCTOBER 28, 2022

The sooner a human-centred perspective is applied to the development of either a drug or device product, the more likely the product will be adopted and used because it’s been designed around what the end consumer wants and needs. This is particularly true in the highly complex ecosystem of drug and device development, where the end consumer is only one of multiple decision-makers in the purchase process.

Documentation 105

Documentation 105

STAT

OCTOBER 28, 2022

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

96

96

ISPE

OCTOBER 28, 2022

International Collaboration and Reliance: Regulatory Panel Discussion at the 2022 ISPE Singapore Conference. Trudy Patterson. Fri, 10/28/2022 - 13:06. iSpeak Blog. iSpeak. International Collaboration and Reliance: Regulatory Panel Discussion at the 2022 ISPE Singapore Conference. Robert W. Tribe. 28 October 2022. At the ISPE Singapore Conference on 17 August 2022 during an online panel discussion, four international regulators discussed how the Covid-19 pandemic had taught regulators to look for

FDA 97

FDA Vaccines Dosage Documentation 97

STAT

OCTOBER 28, 2022

As real-world data (RWD) and real-world evidence (RWE) continue to share the limelight in pharmacoepidemiologic and pharmacoeconomic journals and congresses, the demand for defining RWD and RWE as well as a framework for leveraging real-world research has never been greater. One of the most pressing concerns involves what constitutes “regulatory grade” real-world data and real-world evidence, and when sponsors need to ensure that research conducted using data other than those gener

91

91

pharmaphorum

OCTOBER 28, 2022

During Reuters Pharma 2022, in Nice, France, pharmaphorum web editor Nicole Raleigh briefly spoke to Within3’s CEO Lance Hill, following his talk, “Medical affairs takes over: technologies to help unlock the power of insights and gain strategic ground”. In the video below, Hill discusses the recent fusion of people and technology and how medical affairs can bring real-world insights and real-world science to the table, as well as real-time understanding.

98

98

European Pharmaceutical Review

OCTOBER 28, 2022

A new report , Addressing Europe’s Medicine Exodus by Teva called on legislators to ensure a safer, more secure supply of essential medicines for EU patients, by cutting reliance on low-cost markets. Teva stated distant suppliers and supply chains, weakened by pressures such as inflation are at risk. Europe may not be able to guarantee a reliable supply of necessary drugs alongside rising demand.

Pharmaceutical Companies 91

Pharmaceutical Companies Pharmaceutical Companies 91

Pharmacy Times

OCTOBER 28, 2022

Covis announced positive topline results for 2 new medications that can treat patients with moderate to severe stable chronic obstructive pulmonary disease.

123

123

Drug Topics

OCTOBER 28, 2022

Pharmacists play a significant role in patient education regarding COVID-19 vaccines.

Vaccines 98

Vaccines 98

Pharmacy Times

OCTOBER 28, 2022

The estimation of glomerular filtration rate based on cystatin C could provide a more robust prediction of cardiovascular disease and mortality in patients.

120

120

The Guardian - Pharmaceutical Industry

OCTOBER 28, 2022

Wes Streeting and Jonathan Reynolds test water with pharma firm GSK as party takes on Rishi Sunak As Rishi Sunak emerged as the UK’s next prime minister this week, an experiment was taking place on the outskirts of Stevenage. Huddled around the fume cupboards and petri dishes of GlaxoSmithKline’s global research lab, two of Labour’s frontbench team were testing the water with big business.

77

77

Pharmacy Times

OCTOBER 28, 2022

Results demonstrate improved progression-free survival in the overall patient population and in a prespecified biomarker subgroup of tumors with alterations in specific genes, AstraZeneca says.

73

73

PharmaVoice

OCTOBER 28, 2022

Top women execs speak to the leadership skills they are embracing as the industry adjusts to a new normal.

98

98

Drug Topics

OCTOBER 28, 2022

Your weekly roundup of the latest news from Drug Topics®.

98

98

Pharmaceutical Technology

OCTOBER 28, 2022

On 24 October, American vaccine developer Vaxcyte shared positive topline data from a Phase I/II study of its multivalent conjugate pneumococcal vaccine VAX-24 , bringing the 24-valent pneumococcal jab one step closer to market. The vaccine demonstrated a similar safety profile to Pfizer’s marketed 20-serotype shot Prevnar 20 at all assessed doses, and showed non-inferior efficacy.

Vaccines 64

Vaccines FDA Immunization 64

Pharmacy Times

OCTOBER 28, 2022

New clinical outcomes from BICSTaR study indicate sustained impact of the therapy for individuals with HIV.

73

73

BioPharm

OCTOBER 28, 2022

The newly formed partnership between CSafe and BioLife will expand cold chain supply chain solutions for the cell and gene therapy market.

75

75

Pharmacy Times

OCTOBER 28, 2022

School can spread more than knowledge- some researchers suggest that pink eye is most commonly spread among school students.

91

91